This article, published in The Journal of Infectious Diseases, discusses a study examining invasive pneumococcal disease (IPD) cases from 1998 to 2007 from eight sites across the United States to assess the impact of 7-valent pneumococcal conjugate vaccine (PCV-7) introduction. The study finds that seven years after the introduction of PCV-7, an estimated 211,000 fewer cases and 13,000 fewer deaths have occurred. The authors also conclude that although IPD rates caused by serotype 19A and non-PCV7 types have risen, these rates remain low relative to decreases in PCV7-type IPD.

Author(s): Pilishvili T, Lexau C, Farley MM, et al.

Published: 2010

Resource types: Peer-reviewed journal

Diseases: Pneumococcus

Topics: Disease burden and surveillance; Disease/vaccine specific information

Regions: North America and Europe